Acute kidney injury

Journal of the Royal College of Physicians of Edinburgh

Volumn 43, Issue 4, 2013, Pages 323-329

  Anathhanam, S ^a   Lewington, A J P ^b  

^a PINDERFIELDS GENERAL HOSPITAL   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Acute kidney injury; Contrast induced acute kidney injury; Definitions; Epidemiology; Intravenous fluids

Indexed keywords

ACUTE KIDNEY FAILURE; ARTICLE; BODY FLUID; CAUSAL ATTRIBUTION; CLINICAL ASSESSMENT; CONTRAST INDUCED NEPHROPATHY; CONVALESCENCE; DISEASE DURATION; DISEASE SEVERITY; FLUID BALANCE; FOLLOW UP; HUMAN; HYPOVOLEMIA; KIDNEY FUNCTION; MEDICATION THERAPY MANAGEMENT; PATIENT CARE; PATIENT IDENTIFICATION; PATIENT REFERRAL; RISK REDUCTION;

ACUTE KIDNEY INJURY; CONTRAST INDUCED ACUTE KIDNEY INJURY; DEFINITIONS; EPIDEMIOLOGY; INTRAVENOUS FLUIDS;

ACUTE KIDNEY INJURY; BIOLOGICAL MARKERS; CONTRAST MEDIA; CREATININE; HUMANS; REFERRAL AND CONSULTATION; RENAL REPLACEMENT THERAPY; URINE;

EID: 84899678104     PISSN: 14782715     EISSN: None     Source Type: Journal    
DOI: 10.4997/JRCPE.2013.412     Document Type: Article

References (26)

1. The National Confidential Enquiry into Patient Outcome and Death. Adding insult to injury: a review of care of patients who died in hospital with a primary diagnosis of acute kidney injury (acute renal failure). London: NCEPOD; 2009.
2. Hawkes N. Acute kidney injury is a more important safety issue than MRSA, says NICE. BMJ 2013; 347:f5302. http://dx.doi.org/10.1136/bmj.f5302
3. National Institute for Health and Care Excellence. Acute kidney injury: NICE clinical guideline 169. London: NICE; 2013.
4. The Royal College of Physicians of Edinburgh UK Consensus Conference on 'Management of acute kidney injury: the role of fluids, e-alerts and biomarkers'. Edinburgh: RCPE; 2012.
5. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical practice guideline for acute kidney injury. Kidney Inter Suppl 2012;2:1-138. http://dx.doi.org/10.1038/kisup.2012.1
6. Bellomo R, Ronco C, Kellum JA et al. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-12. http://dx.doi.org/10.1186/cc2872
7. Mehta RL, Kellum JA, Shah SV et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31. http://dx.doi.org/10.1186/cc5713
8. Finlay S, Bray B, Lewington AJ et al. Identification of risk factors associated with acute kidney injury in patients admitted to acute medical units. Clin Med 2013; 13:233-8. http://dx.doi.org/10.7861/clinmedicine.13-3-233
9. Lewington A, Kanagasundaram S. Acute kidney injury clinical practice guidelines. Hampshire: UK Renal Association; 2011.
10. Chawla LS, Amdur RL, Amodeo S et al. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 2011; 79:1361-9. http://dx.doi.org/10.1038/ki.2011.42
11. Taylor J. Calculating the cost, acute kidney injury. A Health Services Journal Supplement. London: HSJ; 2011.
12. Lewington AJ, Cerda J, Mehta RL. Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int 2013; 84:457-67. http://dx.doi.org/10.1038/ki.2013.153
13. Murray PT, Mehta RL, Shaw A et al. Current use of biomarkers in acute kidney injury. Kidney Int 2013. Forthcoming.
14. Haase M, Bellomo R, Devarajan P. Accuracy of neutrophil gelatinaseassociated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 54:1012-24. http://dx.doi.org/10.1053/j.ajkd.2009.07.020
15. Royal College of Physicians. Future hospitals: caring for medical patients. London: RCP; 2013.
16. Nitsch D, Tomlinson LA. Safety of coprescribing NSAIDs with multiple antihypertensive agents. BMJ 2013; 346:e8713.
17. Tomlinson LA, Abel GA, Chaudhry AN, Tomson CR, Wilkinson IB et al. ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study. PLoS ONE 2013;8:e78465. http://dx.doi.org/10.1371/journal.pone.0078465
18. Annane D, Siami S, Jaber S et al. Effects of fluid resuscitation with colloids versus crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 2013; 310:1809-17. http://dx.doi.org/10.1001/jama.2013.280502
19. Myburgh JA, Finfer S, Bellomo R et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012;367: 1901-11. http://dx.doi.org/10.1056/NEJMoa1209759
20. Perner A, Haase, N, Guttormsen AB et al. Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis. N Engl J Med 2012; 367:124-34. http://dx.doi.org/10.1056/NEJMoa1204242
21. MHRA. Drug safety update. June 2013 vol 6, issue 11: S1.
22. Lewington A, MacTier R, Hoefield R et al. Prevention of contrast induced acute kidney injury (CI-AKI). Hampshire: The Renal Association, British Cardiovascular Intervention Society and the Royal College of Radiologists; 2013.
23. The Royal College of Radiologists. Standards for intravascular contrast agent administration to adult patients. 2nd edn. London: The Royal College of Radiologists; 2010.
24. www.survivingsepsis.org. The surviving sepsis campaign.
25. UK Renal Pharmacy Group. Acute kidney injury - medication optimisation toolkit. Surrey: UK Renal Pharmacy Group; 2012.
26. Selby NM, Crowley L, Fluck RJ et al. Use of electronic results reporting to diagnose and monitor AKI in hospitalized patients. CJASN 2012; 7:533-40.